Elaine Johnston is "a highly experienced lawyer who is always great to work with" and is "absolutely excellent for merger work".
Peers and clients say:
"She is a very capable competition specialist."
"Elaine is definitely one of the best lawyers on the list."
"Ms Johnston is an excellent lawyer."
Elaine Johnston is head of Allen & Overy's US antitrust practice and co-head of the global antitrust practice. She handles matters in a wide range of industries, including banking and financial services, pharmaceuticals, healthcare, oil and gas, and industrial products. Elaine has been featured in Chambers USA, Euromoney’s Guide to the World’s Leading Competition and Antitrust Lawyers, and Global Competition Review: Women in Antitrust 2016.
Elaine represents merging parties before the US DOJ and the FTC, as well as companies in non-merger investigations. Elaine has handled antitrust litigation, representing the Belarusian Potash Company, Experian and Saudi Aramco. She regularly advises companies on business conduct, including distribution, licensing, patent pools, information exchanges and benchmarking.
Elaine’s recent experience includes advising WillScot on its US$6.6 billion merger with Mobile Mini; global healthcare company BTG on its US$4.2 billion acquisition by Boston Scientific; and Fresenius Kabi on its agreement to acquire Akorn Inc for US$4.3 billion (abandoned for non-antitrust reasons).
Elaine is a member of the American Bar Association (antitrust section) and the New York State Bar Association (secretary, antitrust section). She is a former associate editor of the Antitrust Law Journal and a frequent speaker at antitrust conferences.
Elaine received her LLM from the University of Michigan (Fulbright scholar); and her BA (Hons) and MA from Clare College, Cambridge University.
Allen & Overy's global antitrust and competition practice comprises over 120 specialists operating across APAC, Europe and North America. The practice advises corporate clients and financial institutions on their global antitrust transactions, policies, litigation and regulatory strategies, and has acted on some of the highest-profile and most complex cases in recent years.